Barclays Analysts Reiterate 'Overweight' Rating for JBS Stock Amid Expansion Plans
Trendline

Barclays Analysts Reiterate 'Overweight' Rating for JBS Stock Amid Expansion Plans

What's Happening? Barclays analysts have reaffirmed an 'overweight' rating for JBS stock, setting an average price target of $18.33. This positive outlook comes as JBS, a global protein processor, continues its strategic expansion efforts. The company recently announced a partnership with Mantra Inv
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.